Psychiatric Disorders: Clinical Trials

4 trials for Psychiatric Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 2
Phase 32Completed 1, Recruiting 1

Follow Psychiatric Disorders: new trials by email Literature Review of Psychiatric Disorders trials Research Report on Psychiatric Disorders

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety
Gaze-Contingent Music Reward Therapy - Psychiatric Disorders, Anxiety Disorders
Phase 2RecruitingNational Institute of Mental Health (NIMH)1502024-12-042026-11-09
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
Melatonin, Quetiapine, Placebo - Psychiatric Disorders, Insomnia
Phase 2 / Phase 3RecruitingLone Baandrup2552023-09-182025-04-24
Can Brief-mindfulness Interventions Improve Psychiatric Symptoms?
Mindfulness-oriented intervention - Psychiatric Disorders
Phase 2 / Phase 3CompletedLady Davis Institute202017-05-192020-09-16
Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial
Family Therapy based on Structural Family Therapy, Group Therapy, Psychoeducational Sessions - Substance Use Disorders, Risk Behavior
Phase 2CompletedUniversity of Miami1902011-01-012015-12-16

Narrower conditions

Mental Disorders (4)  ·  Anxiety Disorders (1)  ·  Risk-Taking (1)  ·  Sleep Initiation and Maintenance Disorders (1)  ·  Substance-Related Disorders (1)

Broader conditions

Behavior (1)  ·  Chemically-Induced Disorders (1)  ·  Dyssomnias (1)  ·  Nervous System Diseases (1)  ·  Sleep Disorders, Intrinsic (1)  ·  Sleep Wake Disorders (1)

Interventions

Melatonin (1)  ·  Psychotherapy, Group (1)  ·  Quetiapine Fumarate (1)

Sponsors

Lady Davis Institute (1)  ·  Lone Baandrup (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  University of Miami (1)

Countries

United States (2)  ·  Canada (1)  ·  Denmark (1)

Top investigators

Daniel A. Santisteban, Ph.D. (1)  ·  Daniel S Pine, M.D. (1)  ·  Lone Baandrup, MD (1)  ·  Maite P. Mena, Psy.D. (1)

NIH funding

2023 (1), R01DA027920 (1)